Organovo Holdings, Inc.
ONVO
株式のランク
#35999
Organovo Holdings, Inc. is a biotechnology firm that specializes in engineering... Organovo Holdings, Inc. is a biotechnology firm that specializes in engineering sophisticated 3D tissues designed to accurately mimic critical facets of human diseases. Central to its operations is a comprehensive 3D human tissue platform, which features the company's proprietary NovoGen Bioprinters. These automated devices are crucial for fabricating complex, living 3D tissues from mammalian cells. The platform also includes supporting technologies necessary for creating specialized "bio-inks" and for the bioprinting of multi-cellular tissues with intricate structures. Organovo supplies specific products, such as ExVive human liver tissue and ExVive human kidney tissue, which are employed for predictive preclinical evaluation of investigational drug compounds. The company was founded in 2007 and maintains its corporate headquarters in Solana Beach, California.
株価
$2.00
最終同期: 2025-05-19
時価総額
$2.93M
変化（1日）
-3.38%
変化（1年）
656.14%
国
US
取引 Organovo Holdings, Inc. (ONVO)
カテゴリー
Healthcare
Organovo Holdings, Inc.（ONVO）の株価履歴
終値の最高値: $5.13 （2025-03-01）
終値の最安値: $131.45 （2014-11-01）
終値の最安値: $131.45 （2014-11-01）
Organovo Holdings, Inc. の株価履歴（2014 ～ 2026）
年間株価パフォーマンス
| 年 | パフォーマンス |
|---|---|
| 2025 | 6.61% |
| 2024 | -65.68% |
| 2023 | -24.35% |
| 2022 | -61.52% |
| 2021 | -70.29% |
| 2020 | -31.30% |
| 2019 | -29.19% |
| 2018 | 153.68% |
| 2014 | 0.00% |
類似企業または競合の株価
| 企業 | 株価 | 変化率 1年% | 国 |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $761.12 | 8.18% |
CH
|
